Skip to main content
OpenTrials

Clinical trial condition

Breast Neoplasms

Explore clinical trials studying Breast Neoplasms. Study availability and eligibility vary by location and protocol.

609 public trials 216 recruiting studies
Refine in advanced search Browse all conditions

Breast Neoplasms trial results

Completed

A Study of XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3)

NCT03752398

Conditions
Adenocarcinoma, Advanced Solid Tumors, Breast Carcinoma That is Estrogen Receptor, Progesterone Receptor, and Her2 Negative, +95 more
Locations
  • UC San Diego Moores Cancer Center San Diego, California, United States
  • University of Colorado Hospital - Anschutz Cancer Pavilion Aurora, Colorado, United States
  • Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
View all 18 locations
View Trial Details
Completed

A Study to Evaluate Safety/Tolerability of Immunotherapy Combinations in Participants With Triple-Negative Breast Cancer or Gynecologic Malignancies

NCT03719326

Conditions
Adnexal Diseases, Breast Diseases, Breast Neoplasms, +19 more
Locations
  • Scottsdale Healthcare Hospitals dba Honor Health Research Institute Scottsdale, Arizona, United States
  • Arizona Clinical Research Center Tucson, Arizona, United States
  • University of California, Los Angeles Los Angeles, California, United States
  • Rocky Mountain Cancer Centers (Aurora) Aurora, Colorado, United States
View all 27 locations
View Trial Details
Completed

Study of Talimogene Laherparepvec With Atezolizumab for Triple Negative Breast Cancer and Colorectal Cancer With Liver Metastases

NCT03256344

Conditions
Breast Diseases, Breast Neoplasms, Colonic Diseases, +15 more
Locations
  • University of California Los Angeles Los Angeles, California, United States
  • Columbia University Medical Center New York, United States
  • Stony Brook University Stony Brook, New York, United States
  • Liverpool Hospital Liverpool, New South Wales, Australia
View all 17 locations
View Trial Details
Completed

Study of TT-00420 (Tinengotinib) Tablet as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors

NCT04742959

Conditions
Adenocarcinoma, Advanced Solid Tumor, Biliary Tract Diseases, +57 more
Locations
  • City of Hope Duarte, California, United States
  • The University of Chicago Chicago, Illinois, United States
  • Rutgers Cancer Institute New Brunswick, New Jersey, United States
  • Gabrail Cancer Center Research Canton, Ohio, United States
View Trial Details
Completed

A Study of the CD73 Inhibitor LY3475070 Alone or in Combination With Pembrolizumab in Participants With Advanced Cancer

NCT04148937

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Cancer, +52 more
Locations
  • Sarah Cannon Research Institute at HealthOne Denver, Colorado, United States
  • Florida Cancer Specialists ORLANDO/DDU Lake Mary, Florida, United States
  • START Midwest Grand Rapids, Michigan, United States
  • Washington University Medical School St Louis, Missouri, United States
View Trial Details
Completed

A Study of Atezolizumab and Paclitaxel Versus Placebo and Paclitaxel in Participants With Previously Untreated Locally Advanced or Metastatic Triple Negative Breast Cancer (TNBC)

NCT03125902

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations
  • Stanford Cancer Center Stanford, California, United States
  • Florida Cancer Specialists; Department of Oncology Fort Myers, Florida, United States
  • Florida Cancer Specialist, North Region St. Petersburg, Florida, United States
  • Northwest Georgia Oncology Centers PC - Marietta Marietta, Georgia, United States
View all 161 locations
View Trial Details

Related conditions